8E2R image
Deposition Date 2022-08-15
Release Date 2023-01-11
Last Version Date 2023-10-25
Entry Detail
PDB ID:
8E2R
Title:
Crystal structure of TadAC-1.14
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.22 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:tRNA-specific adenosine deaminase 1.14
Chain IDs:A, B
Chain Length:167
Number of Molecules:2
Biological Source:Escherichia coli
Primary Citation
Improved cytosine base editors generated from TadA variants.
Nat.Biotechnol. 41 686 697 (2023)
PMID: 36624149 DOI: 10.1038/s41587-022-01611-9

Abstact

Cytosine base editors (CBEs) enable programmable genomic C·G-to-T·A transition mutations and typically comprise a modified CRISPR-Cas enzyme, a naturally occurring cytidine deaminase, and an inhibitor of uracil repair. Previous studies have shown that CBEs utilizing naturally occurring cytidine deaminases may cause unguided, genome-wide cytosine deamination. While improved CBEs that decrease stochastic genome-wide off-targets have subsequently been reported, these editors can suffer from suboptimal on-target performance. Here, we report the generation and characterization of CBEs that use engineered variants of TadA (CBE-T) that enable high on-target C·G to T·A across a sequence-diverse set of genomic loci, demonstrate robust activity in primary cells and cause no detectable elevation in genome-wide mutation. Additionally, we report cytosine and adenine base editors (CABEs) catalyzing both A-to-I and C-to-U editing (CABE-Ts). Together with ABEs, CBE-Ts and CABE-Ts enable the programmable installation of all transition mutations using laboratory-evolved TadA variants with improved properties relative to previously reported CBEs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures